1. Home
  2. VRME vs WINT Comparison

VRME vs WINT Comparison

Compare VRME & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRME
  • WINT
  • Stock Information
  • Founded
  • VRME 1999
  • WINT 1992
  • Country
  • VRME United States
  • WINT United States
  • Employees
  • VRME N/A
  • WINT N/A
  • Industry
  • VRME EDP Services
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VRME Technology
  • WINT Health Care
  • Exchange
  • VRME Nasdaq
  • WINT Nasdaq
  • Market Cap
  • VRME 6.4M
  • WINT 5.3M
  • IPO Year
  • VRME N/A
  • WINT 1995
  • Fundamental
  • Price
  • VRME $0.63
  • WINT $0.38
  • Analyst Decision
  • VRME Buy
  • WINT Hold
  • Analyst Count
  • VRME 1
  • WINT 1
  • Target Price
  • VRME $1.50
  • WINT $7.00
  • AVG Volume (30 Days)
  • VRME 211.9K
  • WINT 1.2M
  • Earning Date
  • VRME 11-12-2024
  • WINT 11-27-2024
  • Dividend Yield
  • VRME N/A
  • WINT N/A
  • EPS Growth
  • VRME N/A
  • WINT N/A
  • EPS
  • VRME N/A
  • WINT N/A
  • Revenue
  • VRME $25,259,000.00
  • WINT N/A
  • Revenue This Year
  • VRME N/A
  • WINT N/A
  • Revenue Next Year
  • VRME $5.00
  • WINT N/A
  • P/E Ratio
  • VRME N/A
  • WINT N/A
  • Revenue Growth
  • VRME N/A
  • WINT N/A
  • 52 Week Low
  • VRME $0.58
  • WINT $0.33
  • 52 Week High
  • VRME $2.45
  • WINT $14.75
  • Technical
  • Relative Strength Index (RSI)
  • VRME 36.19
  • WINT 30.45
  • Support Level
  • VRME $0.58
  • WINT $0.33
  • Resistance Level
  • VRME $0.65
  • WINT $0.42
  • Average True Range (ATR)
  • VRME 0.08
  • WINT 0.05
  • MACD
  • VRME 0.02
  • WINT 0.03
  • Stochastic Oscillator
  • VRME 20.38
  • WINT 11.11

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: